Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Ordinary Shares, $0.0001 par value
-
Shares outstanding
-
173M
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
17.6M
-
Shares change
-
+3.23M
-
Total reported value, excl. options
-
$699M
-
Value change
-
+$106M
-
Number of buys
-
26
-
Number of sells
-
-13
-
Price
-
$41.57
Significant Holders of Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) as of Q2 2023
53 filings reported holding GPCR - Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value as of Q2 2023.
Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.6M shares
of 173M outstanding shares and own 10.21% of the company stock.
Largest 10 shareholders include Deep Track Capital, LP (2.65M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.77M shares), BVF INC/IL (1.75M shares), Monashee Investment Management LLC (1.37M shares), FMR LLC (1.24M shares), Driehaus Capital Management LLC (1.14M shares), FEDERATED HERMES, INC. (1.01M shares), Casdin Capital, LLC (997K shares), T. Rowe Price Investment Management, Inc. (655K shares), and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (628K shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.